|
1
|
Bulycheva E, Rauner M, Medyouf H, Theurl
I, Bornhäuser M, Hofbauer LC and Platzbecker U: Myelodysplasia is
in the niche: Novel concepts and emerging therapies. Leukemia.
29:259–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Méndez-Ferrer S, Michurina TV, Ferraro F,
Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A,
Enikolopov GN and Frenette PS: Mesenchymal and haematopoietic stem
cells form a unique bone marrow niche. Nature. 466:829–834. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arai F and Suda T: Maintenance of
quiescent hematopoietic stem cells in the osteoblastic niche. Ann N
Y Acad Sci. 1106:41–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bowers M, Zhang B, Ho Y, Agarwal P, Chen
CC and Bhatia R: Osteoblast ablation reduces normal long-term
hematopoietic stem cell self-renewal but accelerates leukemia
development. Blood. 125:2678–2688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raaijmakers MH, Mukherjee S, Guo S, Zhang
S, Kobayashi T, Schoonmaker JA, Ebert BL, Al-Shahrour F, Hasserjian
RP, Scadden EO, et al: Bone progenitor dysfunction induces
myelodysplasia and secondary leukaemia. Nature. 464:852–857. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brennan-Speranza TC and Conigrave AD:
Osteocalcin: An osteoblast-derived polypeptide hormone that
modulates whole body energy metabolism. Calcif Tissue Int. 96:1–10.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Youngstrom DW, Dishowitz MI, Bales CB,
Carr E, Mutyaba PL, Kozloff KM, Shitaye H, Hankenson KD and Loomes
KM: Jagged1 expression by osteoblast-lineage cells regulates
trabecular bone mass and periosteal expansion in mice. Bone.
91:64–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakuishi K, Jayaraman P, Behar SM,
Anderson AC and Kuchroo VK: Emerging Tim-3 functions in
antimicrobial and tumor immunity. Trends Immunol. 32:345–349. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vardiman JW, Thiele J, Arber DA, Brunning
RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM,
Hellström-Lindberg E, Tefferi A and Bloomfield CD: The 2008
revision of the World Health Organization (WHO) classification of
myeloid neoplasms and acute leukemia: Rationale and important
changes. Blood. 114:937–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malcovati L, Della Porta MG, Strupp C,
Ambaglio I, Kuendgen A, Nachtkamp K, Travaglino E, Invernizzi R,
Pascutto C, Lazzarino M, et al: Impact of the degree of anemia on
the outcome of patients with myelodysplastic syndrome and its
integration into the WHO classification-based Prognostic Scoring
System (WPSS). Haematologica. 96:1433–1440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schepers K, Pietras EM, Reynaud D, Flach
J, Binnewies M, Garg T, Wagers AJ, Hsiao EC and Passegué E:
Myeloproliferative neoplasia remodels the endosteal bone marrow
niche into a self-reinforcing leukemic niche. Cell Stem Cell.
13:285–299. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manavalan JS, Cremers S, Dempster DW, Zhou
H, Dworakowski E, Kode A, Kousteni S and Rubin MR: Circulating
osteogenic precursor cells in type 2 diabetes mellitus. J Clin
Endocrinol Metabol. 97:3240–3250. 2012. View Article : Google Scholar
|
|
13
|
Fu R, Peng F, Liu H, Wang Y, Li L, Wang G,
Song J and Shao Z: Clinical significance of osteoblast precursors
and osteoclast precursors in earlier diagnosis and monitoring of
myeloma bone disease. Ann Hematol. 95:1099–1106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Flynn CM and Kaufman DS: Donor cell
leukemia: Insight into cancer stem cells and the stem cell niche.
Blood. 109:2688–2692. 2007.PubMed/NCBI
|
|
15
|
Dong M, Jiao G, Liu H, Wu W, Li S, Wang Q,
Xu D, Li X, Liu H and Chen Y: Biological silicon stimulates
collagen Type 1 and osteocalcin synthesis in human osteoblast-like
cells through the BMP-2/Smad/RUNX2 signaling pathway. Biol Trace
Elem Res. 173:306–315. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grochowski CM, Loomes KM and Spinner NB:
Jagged1 (JAG1): Structure, expression, and disease associations.
Gene. 576:381–384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kode A, Manavalan JS, Mosialou I, Bhagat
G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R,
et al: Leukaemogenesis induced by an activating β-catenin mutation
in osteoblasts. Nature. 506:240–244. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu R, Gao S, Peng F, Li J, Liu H, Wang H,
Xing L and Shao Z: Relationship between abnormal osteoblasts and
cellular immunity in multiple myeloma. Cancer Cell Int. 14:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sakuishi K, Jayaraman P, Behar SM,
Anderson AC and Kuchroo VK: Emerging Tim-3 functions in
antimicrobial and tumor immunity. Trends Immunol. 32:345–349. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tao JL, Li LJ, Fu R, Wang HQ, Jiang HJ,
Yue LZ, Zhang W, Liu H, Ruan EB, Qu W, et al: Elevated TIM3+
hematopoietic stem cells in untreated myelodysplastic syndrome
displayed aberrant differentiation, overproliferation and decreased
apoptosis. Leuk Res. 38:714–721. 2014. View Article : Google Scholar : PubMed/NCBI
|
